Results from the Reducing with Metformin Vascular Adverse Lesions (REMOVAL) study show for the first time that metformin has a cardiovascular benefit in patients with type 1 diabetes mellitus (T1DM), although the benefit was limited to tertiary outcomes and was modest. Additional measures are therefore needed to reduce cardiovascular disease in patients with T1DM.

中文翻译：

---

糖尿病：二甲双胍对T1DM的心血管益处

二甲双胍减少血管不良病变（REMOVAL）研究的结果首次显示，二甲双胍对1型糖尿病（T1DM）患者具有心血管益处，尽管益处仅限于三级结局且适度。因此，需要采取其他措施来减少T1DM患者的心血管疾病。